Celestial Biolabs Ltd - Stock Price

  • NSE : CELESTIAL
  • BSE : 532871
  • ISIN CODE : INE221I01017
  • Industry : Pharmaceuticals & Drugs
  • House : Private
Celestial Biolabs Ltd is not traded on BSE/NSE
NSE
3.05
-4.69 %-0.15
BSE
3.36
+2.13 %+0.07

Ratios

Parameter MAR 18  MAR 17  YoY %Change
Operational & Financial Ratios
   Earnings Per Share (Rs)1.531.483.66
   CEPS(Rs)4.942.9468.00
   DPS(Rs)0.000.000.00
   Book NAV/Share(Rs)45.2943.763.50
   Tax Rate(%)15.889.2671.43
Margin Ratios
   Core EBITDA Margin(%)27.6318.1052.67
   EBIT Margin(%)9.669.551.10
   Pre Tax Margin(%)9.609.500.97
   PAT Margin (%)8.078.62-6.39
   Cash Profit Margin (%)26.0517.1751.70
Performance Ratios
   ROA(%)3.113.12-0.51
   ROE(%)3.443.53-2.64
   ROCE(%)3.783.507.88
   Asset Turnover(x)0.380.366.28
   Sales/Fixed Asset(x)0.420.46-9.04
   Working Capital/Sales(x)1.492.34-36.45
Efficiency Ratios
   Fixed Capital/Sales(x)2.412.199.94
   Receivable days123.7295.3729.72
   Inventory Days49.7782.04-39.34
   Payable days4.616.11-24.48
Valuation Parameters
   PER(x)8.5917.55-51.02
   PCE(x)2.668.81-69.78
   Price/Book(x)0.290.59-50.94
   Yield(%)0.000.000.00
   EV/Net Sales(x)0.911.72-46.76
   EV/Core EBITDA(x)3.319.48-65.13
   EV/EBIT(x)9.4617.97-47.34
   EV/CE(x)0.340.61-43.84
   M Cap / Sales0.691.51-54.15
Growth Ratio
   Net Sales Growth(%)10.7417.67-39.23
   Core EBITDA Growth(%)69.08-20.90430.58
   EBIT Growth(%)11.9617.63-32.18
   PAT Growth(%)3.6760.29-93.92
   EPS Growth(%)3.6645.39-91.93
Financial Stability Ratios
   Total Debt/Equity(x)0.090.0810.32
   Current Ratio(x)13.7113.243.61
   Quick Ratio(x)11.967.5159.30
   Interest Cover(x)162.76204.01-20.22
   Total Debt/Mcap(x)0.320.14124.89

Latest News

close